Recent Awards & Accolades
The American Society for Transplantation and Cellular Therapy
ASTCT Public Service Award | 2020
The ASBMT Public Service Award, presented at each year’s ASBMT Annual Meeting. The award “recognizes an individual outside of the ASBMT membership who has advanced the interests of blood and marrow transplantation or given special service to the patients and families that we serve.”
The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 2,200 physicians, investigators and other health care professionals from more than 45 countries. Our mission is dedicated to improving the application and success of bone and marrow transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field.
Marti, Gerry and Meredith,
“You have been so passionate about increasing awareness and education about GVHD. Over the last many years, so have raised money for GVHD education and research, and have educated hundreds of patients/families and BMT professionals about this issue. We all felt that your contributions to the field of transplantation and cellular therapy are exemplary, an example for other patient advocates, and exceed the criteria we consider for this important honor.”
Navneet Majhail, MD, MS
Director | Blood and Marrow Transplant Program
The Leukemia & Lymphoma Society
AWARD – 2019
The progress The Leukemia & Lymphoma Society has made is because of our amazing volunteers who make LLS what it is.
- From setting up (and tearing down!) events
- to folding thank you letters and stuffing envelopes
- to raising funds through our various campaigns
- Caring for loved ones who are going through or recovering from treatment
- to recruiting their company to provide support
- to serving as an Honored Hero
- to recruiting candidates
- and the list goes on
Each year we recognize the unsung heroes among us. Merriam-Webster defines “lifeblood” as a “vital or life-giving force or component.”
The Leukemia & Lymphoma Society
BEATING CANCER IS IN OUR BLOOD.
The Leukemia & Lymphoma Society is at the forefront of the fight to cure cancer. We are the largest nonprofit dedicated to creating a world without blood cancers. Since 1949, we’ve invested nearly $1.3 billion in groundbreaking research, pioneering many of today’s most innovative approaches.
“The Cowden family believes that Meredith is one of the lucky individuals to get a second chance in life after being diagnosed with a blood cancer at the age of 19. The Foundation is their way of giving back and trying to make change in the blood cancer world. Since its formation in 2007, The Meredith A. Cowden Foundation has raised funds for blood cancer research and awareness, as well as Graft vs. Host Disease, a condition that is a complication of a bone marrow transplant. Through this focus, The Meredith A. Cowden Foundation has also been a supporter and partner to the Leukemia & Lymphoma Society.
In addition to supporting LLS through travel grants, they have also been our Collegiate of The Year scholarship sponsor. Since 2010 the Meredith A. Cowden Foundation has been planning and putting on the National Graft vs. Host Disease Symposium. We are excited to be partnering on the symposium this coming fall 2020.”
“Through perseverance many people win success out of what seemed destined to be certain failure.”
In The News
Raising Awareness & The Quality Of Life For Patients
The Meredith A. Cowden Foundation is committed to:
Providing funding for research to prevent, treat and cure Graft vs. Host Disease (GvHD).
Educating physicians, researchers, patients, and the general public concerning GvHD and late effects of transplants, their prevention, treatment and cure.
Providing general information concerning the blood cancers and their treatment, with a special emphasis on the treatment of leukemia and bone marrow and stem cell transplantation; and
Providing resources for The Leukemia & Lymphoma Society to support programs designed to enhance the quality of life of patients and their families during treatment.